– Samir Gharib , MBA, Promoted to President – SAN FRANCISCO --(BUSINESS WIRE)--Jan. 5, 2022-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need,